“…Even very low levels (a few %) of amorphous material can have a dramatic effect on both the physical and chemical properties of pharmaceuticals and techniques capable of reliably quantifying such amorphous content to low levels are not routinely available (9)(10)(11). The characterisation methods commonly used for determining amorphous content in pharmaceutical materials include powder X-ray diffraction (PXRD) (5), calorimetric methods such as differential scanning calorimetry (DSC) (12)(13)(14), isothermal microcalorimetry (IMC) (15,16) and solution calorimetry (17), and spectroscopic methods such as solid-state NMR (18,19), near-infrared (12) and Raman (20,21). In general, the limit of detection and limit of quantification of the PXRD and DSC are >5%, and the determination of experimental parameters for calorimetric methods can also be time consuming (9).…”